January 28, 2021
January 28, 2021 | New products for high-content imaging, virus reagents and enrichment, software for small molecule design, and pharmacokinetic simulation. Plus: acquisitions in drug discovery services and partnerships for data analysis, single cell analysis, machine learning, and more.
Certara has released
version 20 of its Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform. Simcyp PBPK Simulator version 20 offers new and enhanced models for maternal health, such as assessing drug performance during pregnancy and lactation. It also automates the assessment of virtual bioequivalence to attain biowaivers and analyzes drugs delivered via long-acting injectable delivery. Additional upgrades have been made to the Simcyp PBPK Simulator’s animal, liver, absorption, and skin models. Press release.